Poliomyelitis outbreak in Israel in 1988: A report with two commentaries

Lancet

Volumn 335, Issue 8699, 1990, Pages 1192-1198

  Slater, P E ^a   Orenstein, W A ^b   Morag, A ^c   Avni, A ^a   Handsher, R ^d   Green, M S ^e   Costin, C ^a   Yarrow, A ^a   Rishpon, S ^f   Havkin, O ^g   Ben Zvi O, T ^a   Kew, M ⁱ   Rey, M ^j   Epstein, I ^a   Swartz, T A ^h   Melnick, J L ^k  

^a MINISTRY OF HEALTH   (Israel)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e Occupational Health and Rehabilitation Institute Israel   (Israel)

^f Haifa District Health Office   (Israel)

^g Hadera Subdistrict Health Office ^*

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; FEMALE; HUMAN; INFECTION CONTROL; ISRAEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEWAGE; WATER CONTAMINATION;

EID: 0025375806     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yekutiel P, Levinger EL, Muhsam HV, Yekutiel MP. Poliomyelitis outbreak in Israel, 1950-51. Bull WHO 1955; 12: 651-76.
2. Yofe J, Goldblum N, Eylan E, Melnick JL. An outbreak of poliomyelitis in Israel in 1961 and the use of attenuated type 1 vaccine in its control. Am J Hyg 1962; 76:225-38.
3. Swartz TA, Ben-Porath E, Kanaaneh H, Leitner L, Goldblum N. Comparison of inactivated poliovirus vaccine and oral poliovirus vaccine programs in Israel. Rev Infect Dis 1984; 6 (suppl 6): S556-61.
4. Swartz TA. Experience with the control of poliomyelitis in Israel, the West Bank and Gaza Strip by use of OPV, IPV and OPV-IPV. Presented at Conference on poliomyelitis vaccines: re-evaluating policy options. National Academy of Sciences, Washington, DC, January, 1988.
5. Goldblum N, Swartz T, Gerichter CB, Handsher R, Lasch EE, Melnick JL. Natural history of poliomyelitis in Israel, 1949-1982. Prog Med Virol 1984; 29: 115-23.
6. Hinman AR, Foege WH, de Quadros CA, Patriarca PA, Orenstein WA, Brink EW. The case for global eradiction of poliomyelitis. Bull WHO 1987; 65: 835-40.
7. Gelfand HM, LeBlanc DR, Fox JP, Holguin AH. Susceptibility of infants to infection with natural (wild) and attenuated (vaccine) strains of polioviruses. Fifth International Poliomyelitis Conference: Copenhagen, Denmark, 1960. Philadelphia: JB Lippincott, 1961. 285-89.
8. Patriarca PA, Palmeira G, Lima Filho J, et al. Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet 1988, i: 429-33.
9. Fox JP, Hall C. Viruses in families. Littleton: PSG Publishing Co, 1980.
10. Soloviev VD. Problems connected with live polio vaccine. Fifth International Poliomyelitis Conference: Copenhagen, Denmark, 1960. Philadelphia: JB Lippincott, 1961: 403-10.
11. Onorato IM, Modlin JF, Bernier RH, McBean AM, Thorns ML. Intestinal immunity induced by enhanced potency IPV and OPV. 27th Interscience Conference of Antimicrobial Agents and Chemotherapy, New York, 1987.
12. McBean AM, Thorns ML, Albrecht P, Cuthie JC, Bernier R. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol 1988; 128: 615-28.
13. Institute of Medicine. An evaulation of poliomyelitis vaccine policy options. National Academy of Sciences Publication no IOM 88-04: Washington, DC, 1988.
14. Melnick JL. Poliomyelitis vaccines, an appraisal after 25 years. Comprehensive Ther 1980; 5: 6-14.
15. Bemier RH. Improved inactivated poliovirus vaccine, an update. Pediatr Infect Dis J 1986; 5: 289-92.
16. Melnick JL. Vaccination against poliomyelitis, present possibilities and future prospects. Am J Publ Health 1988; 78:304-05.
17. McBean AM, Modlin JF. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States. Pediatr Infect Dis J 1987; 6: 881-87.
18. Katz SL. Controversies in immunization. Pediatr Infect Dis J 1987; 6: 607-13.
19. Lasch EE, Abed Y, Marcus O, Gerichter CB, Melnick JL. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country, five years after. Develop Biol Standard 1986; 65: 137-43.
20. Tulchinsky TH, Abed Y, Shaheen S, et al. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Publ Health 1989; 79:1648-52.
21. Centers for Disease Control. Preliminary report: paralytic poliomyelitis, Senegal, 1986. MMWR 1987; 36:378-89.
22. EPI/WHO. Manual for immunization programme managers on activities related to polio eradication. Geneva: World Health Organisation, 1989.
23. Hovi T, Cantell K, Houvilainen A, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986; i: 1427-32.